Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity

Free Radical Biology and Medicine

Volumn 36, Issue 3, 2004, Pages 359-370

  Jimenez Lopez, Jose M ^a   Cederbaum, Arthur I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; CYP2E1; Epigallocatechin 3 gallate; Free radicals; HepG2 cells; Iron; Oxidative stress

Indexed keywords

ALCOHOL; ARACHIDONIC ACID; CYTOCHROME P450 2E1; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; GLUTATHIONE; IRON; POLYPHENOL DERIVATIVE;

ARTICLE; CELL PROTECTION; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LIPID PEROXIDATION; LIVER INJURY; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; PRIORITY JOURNAL; TEA;

EID: 1642440239     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.11.016     Document Type: Article

References (74)

1. Bonkovsky H.L., Banner B.F., Lambrecht R.W., Rubin R.B. Iron in liver diseases other than hemochromatosis. Semin. Liver Dis. 16:1996;65-82.
2. Valerio L.G. Jr., Parks T., Petersen D.R. Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury. Alcohol. Clin. Exp. Res. 20:1996;1352-1361.
3. Corrao G., Torchio P., Zambon A., D'Amicis A., Lepore A.R., di Orio F. Alcohol consumption and micronutrient intake as risk factors for liver cirrhosis: a case-control study. Ann. Epidemiol. 8:1998;154-159.
4. French S.W. Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J. Biomed. Sci. 8:2001;20-27.
5. Nordmann R., Ribiere C., Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic. Biol. Med. 12:1992;219-240.
6. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:2002;47-95.
7. Arteel G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology. 124:2003;778-790.
8. Feng Q., Kumagai T., Torii Y., Nakamura Y., Osawa T., Uchida K. Anticarcinogenic antioxidants as inhibitors against intracellular oxidative stress. Free Radic. Res. 35:2001;779-788.
9. McDonough K.H. Antioxidant nutrients and alcohol. Toxicology. 189:2003;89-97.
10. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:1996;933-956.
11. Zhong Z., Froh M., Connor H.D., Li X., Conzelmann L.O., Mason R.P., Lemasters J.J., Thurman R.G. Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am. J. Physiol. Gastrointest. Liver Physiol. 283:2002;957-964.
12. Zhong Z., Froh M., Lehnert M., Schoonhoven R., Yang L., Lind H., Lemasters J.J., Thurman R.G. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 285:2003;1004-1013.
13. Cao J., Xu Y., Chen J., Klaunig J.E. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam. Appl. Toxicol. 29:1996;244-250.
14. Gensler H.L., Timmermann B.N., Valcic S., Wachter G.A., Dorr R., Dvorakova K., Alberts D.S. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea. Nutr. Cancer. 26:1996;325-335.
15. Dreosti I.E., Wargovich M.J., Yang C.S. Inhibition of carcinogenesis by tea: the evidence from experimental studies. Crit. Rev. Food Sci. Nutr. 37:1997;761-770.
16. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011.
17. Mukhtar H., Ahmad N. Green tea in chemoprevention of cancer. Toxicol. Sci. 52:1999;111-117.
18. Yang C.S., Maliakal P., Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42:2002;25-54.
19. Cai Y., Anavy N.D., Chow H.H. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab. Dispos. 30:2002;1246-1249.
20. Cederbaum A.I., Wu D., Mari M., Bai J. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic. Biol. Med. 31:2001;1539-1543.
21. Caro A.A., Cederbaum A.I. Synergistic toxicity of iron and arachidonic acid in HepG2 cells overexpressing CYP2E1. Mol. Pharmacol. 60:2001;742-752.
22. Takahashi H., Johansson I., French S.W., Ingelman-Sundberg M. Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P450 (CYP2E1) in the liver of rats chronically fed ethanol. Pharmacol. Toxicol. 70:1992;347-351.
23. Fernandez-Checa J.C., Hirano T., Tsukamoto H., Kaplowitz N. Mitochondrial glutathione depletion in alcoholic liver disease. Alcohol. 10:1993;469-475.
24. Morimoto M., Hagbjork A.L., Nanji A.A., Ingelman-Sundberg M., Lindros K.O., Fu P.C., Albano E., French S.W. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol. 10:1993;459-464.
25. Nanji A.A., Zhao S., Lamb R.G., Sadrzadeh S.M., Dannenberg A.J., Waxman D.J. Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: relationship to cytochrome P-450 2E1 induction and conjugated diene formation. Alcohol. Clin. Exp. Res. 17:1993;598-603.
26. Tsukamoto H., Horne W., Kamimura S., Niemela O., Parkkila S., Yla-Herttuala S., Brittenham G.M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96:1995;620-630.
27. Chen Q., Cederbaum A.I. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol. Pharmacol. 53:1998;638-648.
28. Sakurai K., Cederbaum A.I. Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol. Pharmacol. 54:1998;1024-1035.
29. Perez M.J., Cederbaum A.I. Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity. Free Radic. Biol. Med. 30:2001;734-746.
30. Cederbaum A.I., Dicker E., Rubin E., Cohen G. The effect of dimethylsulfoxide and other hydroxyl radical scavengers on the oxidation of ethanol by rat liver microsomes. Biochem. Biophys. Res. Commun. 78:1977;1254-1262.
31. Niehaus W.G., Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 6:1968;126-130.
32. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421.
33. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
34. 2+-dependent and independent mitochondrial damage in HepG2 cells that overexpress CYP2E1. Arch. Biochem. Biophys. 408:2002;162-170.
35. Emaus R.K., Grunwald R., Lemasters J.J. Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim. Biophys. Acta. 850:1986;436-448.
36. Dickinson D.A., Forman H.J. Cellular glutathione and thiol metabolism. Biochem. Pharmacol. 64:2002;1019-1026.
37. Wu D., Cederbaum A.I. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria. Hepatology. 35:2002;1420-1430.
38. Chen Q., Galleano M., Cederbaum A.I. Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P4502E1. J. Biol. Chem. 272:1997;14532-14541.
39. Tsukamoto H. Cyp2e1 and ALD. Hepatology. 32:2000;154-156.
40. Miguez M.P., Anundi I., Sainz-Pardo L.A., Lindros K.O. Hepatoprotective mechanism of silymarin: no evidence for involvement of cytochrome P450 2E1. Chem.-Biol. Interact. 91:1994;51-63.
41. Comoglio A., Tomasi A., Malandrino S., Poli G., Albano E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochem. Pharmacol. 50:1995;1313-1316.
42. Beckmann-Knopp S., Rietbrock S., Weyhenmeyer R., Bocker R.H., Beckurts K.T., Lang W., Hunz M., Fuhr U. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacol. Toxicol. 86:2000;250-256.
43. Kim J.Y., Lee S., Kim D.H., Kim B.R., Park R., Lee B.M. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes. J. Toxicol. Environ. Health A. 65:2002;373-381.
44. Henderson M.C., Miranda C.L., Stevens J.F., Deinzer M.L., Buhler D.R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica. 30:2000;235-251.
45. Obermeier M.T., White R.E., Yang C.S. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica. 25:1995;575-584.
46. Muto S., Fujita K., Yamazaki Y., Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 479:2001;197-206.
47. Chen Z.P., Schell J.B., Ho C.T., Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 129:1998;173-179.
48. Chen C., Yu R., Owuor E.D., Kong A.N. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23:2000;605-612.
49. Kuo P.L., Lin C.C. Green tea constituent (-)-epigallocatechin-3-gallate inhibits HepG2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J. Biomed. Sci. 10:2003;219-227.
50. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., Lockwood P., Ueta E., Osaki T., Schuster G. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J. Pharmacol. Exp. Ther. 307:2003;230-236.
51. Wilhelm J. Metabolic aspects of membrane lipid peroxidation. Acta Univ. Carol. Med. Monogr. 137:1990;1-53.
52. van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20:1996;331-342.
53. Guo Q., Zhao B., Shen S., Hou J., Hu J., Xin W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta. 1427:1999;13-23.
54. Murakami C., Hirakawa Y., Inui H., Nakano Y., Yoshida H. Effects of epigallocatechin 3-O-gallate on cellular antioxidative system in HepG2 cells. J. Nutr. Sci. Vitaminol. (Tokyo). 48:2002;89-94.
55. Chen L., Yang X., Jiao H., Zhao B. Tea catechins protect against lead-induced cytotoxicity, lipid peroxidation, and membrane fluidity in HepG2 cells. Toxicol. Sci. 69:2002;149-156.
56. Higuchi A., Yonemitsu K., Koreeda A., Tsunenari S. Inhibitory activity of epigallocatechin gallate (EGCG) in paraquat-induced microsomal lipid peroxidation: a mechanism of protective effects of EGCG against paraquat toxicity. Toxicology. 183:2003;143-149.
57. Guo Q., Zhao B., Li M., Shen S., Xin W. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta. 1304:1996;210-222.
58. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta. 1366:1998;177-196.
59. Lemasters J.J., Qian T., Bradham C.A., Brenner D.A., Cascio W.E., Trost L.C., Nishimura Y., Nieminen A.L., Herman B. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr. 31:1999;305-319.
60. Hoek J.B., Cahill A., Pastorino J.G. Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology. 122:2002;2049-2063.
61. Arteel G.E., Uesugi T., Bevan L.N., Gabele E., Wheeler M.D., McKim S.E., Thurman R.G. Green tea extract protects against early alcohol-induced liver injury in rats. Biol. Chem. 383:2002;663-670.
62. Skrzydlewska E., Ostrowska J., Stankiewicz A., Farbiszewski R. Green tea as a potent antioxidant in alcohol intoxication. Addict. Biol. 7:2002;307-314.
63. Chen A., Zhang L., Xu J., Tang J. The antioxidant (-)-epigallocatechin-3- gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem. J. 368:2002;695-704.
64. Hofmann C.S., Sonenshein G.E. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J. 17:2003;702-704.
65. Khan S.G., Katiyar S.K., Agarwal R., Mukhtar H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 52:1992;4050-4052.
66. Sueoka N., Suganuma M., Sueoka E., Okabe S., Matsuyama S., Imai K., Nakachi K., Fujiki H. A new function of green tea: prevention of lifestyle-related diseases. Ann. N.Y. Acad. Sci. 928:2001;274-280.
67. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem. Pharmacol. 63:2002;21-29.
68. Blot W.J., Chow W.H., McLaughlin J.K. Tea and cancer: a review of the epidemiological evidence. Eur. J. Cancer Prev. 5:1996;425-438.
69. Terao J., Piskula M., Yao Q. Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch. Biochem. Biophys. 308:1994;278-284.
70. Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., Rice-Evans C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 322:1995;339-346.
71. Nakagawa K., Okuda S., Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 61:1997;1981-1985.
72. Ullmann U., Haller J., Decourt J.P., Girault N., Girault J., Richard-Caudron A.S., Pineau B., Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 31:2003;88-101.
73. Canada A.T., Giannella E., Nguyen T.D., Mason R.P. The production of reactive oxygen species by dietary flavonols. Free Radic. Biol. Med. 9:1990;441-449.
74. Hagerman A.E., Dean R.T., Davies M.J. Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch. Biochem. Biophys. 414:2003;115-120.